The expression of NFYA variants was associated with epithelial-mesenchymal transition (EMT) status as reported in breast cancer cells (Dolfini et al., 2019; Okada et al., 2022), but no association was observed for the expression of PCK1 and G6PC (Figure 2A). Here, NFYA is linked to breast carcinoma.